Findings

What do systematic reviews say?

5 questions · 6 findings · 4 reviews · Airways

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 4 · 66.7%Moderate 1 · 16.7%High 0 · 0%

Exercise vs control

Exercise capacity · people with pulmonary hypertension

1 finding from 1 review

Exercise‐based rehabilitation programmes for pulmonary hypertension 2023 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 418 participants
Low

Telerehabilitation vs centre‐based (outpatient) pulmonary rehabilitation

Exercise capacity · Chronic respiratory disease

Telerehabilitation showed no clear difference in exercise capacity ‐6MWD (m) compared with centre‐based (outpatient) pulmonary rehabilitation (moderate certainty).

1 finding from 1 review

Telerehabilitation for chronic respiratory disease 2021 · Cochrane Headline outcomes only
MD 0.06
4 studies · 556 participants
Moderate

Supervised maintenance programme following pulmonary rehabilitation vs usual care

Six‐minute walk distance · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive… 2021 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 639 participants
Low

Telerehabilitation vs no rehabilitation control

Exercise capacity · Chronic respiratory disease

Telerehabilitation may leads to higher exercise capacity ‐ 6MWD (m) compared with no rehabilitation control (low certainty).

2 findings from 1 review

Telerehabilitation for chronic respiratory disease 2021 · Cochrane Headline outcomes only
MD 78.1 [49.6, 106.6]
2 studies · 209 participants
Low
Telerehabilitation for chronic respiratory disease 2021 · Cochrane Headline outcomes only
MD 22.17
2 studies · 94 participants
Low

Intervention not reported

Change in Exercise Capacity (6MWD) · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)

1 finding from 1 review

Guanylate cyclase stimulators for pulmonary hypertension 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 398 participants
Very low